by Eric Christianson | Oct 4, 2026 | Respiratory Medication and Disease State Clinical Pearls
A patient who keeps having asthma exacerbations can be frustrating to manage. It is easy to assume that the patient simply needs a stronger inhaler or additional medications. But before escalating therapy, it is important to figure out why the patient is not getting...
by Eric Christianson | Sep 16, 2026 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
While tramadol is classified as an opioid, there are many practice pearls that make it unique from other traditional opioids. In this blog post, I’ll share my top 5 tramadol practice pearls. Tramadol has weak mu-opioid receptor activity, but it also inhibits the...
by Eric Christianson | Sep 9, 2026 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
In my practice, I most often see amantadine used for dyskinesia and motor symptoms associated with Parkinson’s. It can also be used for medication-induced Parkinsonism. In general, amantadine is not a first-line agent for treating movement disorders, but I think...
by Eric Christianson | Aug 30, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Naltrexone and acamprosate are two commonly used medications for alcohol use disorder (AUD), but the ideal candidate for each medication is different. I will discuss the most important clinical practice pearls and nuggets that will likely show up on your board exam...
by Eric Christianson | Aug 16, 2026 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Osteoarthritis is one of the most common causes of chronic joint pain, and pharmacists and other healthcare professionals encounter medications for osteoarthritis on a regular basis. From NSAIDs and topical therapies to duloxetine, corticosteroid injections, and other...
by Eric Christianson | Aug 12, 2026 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Finerenone (Kerendia) is a relatively newer medication for the management of chronic kidney disease (CKD) in patients with type 2 diabetes and heart failure with preserved ejection fraction. In addition to these indications, there was a recent study that showed...
